Flagship of China’s ‘Godfather of Cardiovascular Surgery’ Slices Towards IPO
The maker of cardiovascular interventional medical devices has been approved for a listing on the Hong Kong Stock ExchangeKey Takeaways:OrbusNeich Medical has been approved for a Hong Kong IPO, and…
